Cushing's Syndrome

• Cushing’s syndrome


  Refers to the features of prolonged high levels of glucocorticoids in the body
• Groups of corticosteroid hormones

  • Glucocorticoids (e.g., cortisol)
  • Mineralocorticoids (e.g., aldosterone)
• Cortisol


  The primary natural glucocorticoid hormone produced by the adrenal glands
• Cushing’s disease


  Refers to a pituitary adenoma secreting excessive adrenocorticotropic hormone (ACTH), stimulating excessive cortisol release from the adrenal glands
• Cushing’s disease is not the only cause of Cushing’s syndrome
• The prolonged use of exogenous corticosteroids, such as prednisolone or dexamethasone, often causes Cushing’s syndrome
• Exogenous


  Refers to when it originates outside the body
• Features of Cushing’s syndrome

  • Round face (known as a “moon face”)
  • Central obesity
  • Abdominal striae (stretch marks)
  • Enlarged fat pad on the upper back (known as a “buffalo hump”)
  • Proximal limb muscle wasting
  • Male pattern facial hair in women (hirsutism)
  • Easy bruising and poor skin healing
  • Hyperpigmentation of the skin in patients with Cushing’s disease
• Metabolic effects of Cushing’s syndrome

  • Hypertension
  • Cardiac hypertrophy
  • Type 2 diabetes
  • Dyslipidaemia (raised cholesterol and triglycerides)
  • Osteoporosis
• Mental health effects of Cushing’s syndrome

  • Anxiety
  • Depression
  • Insomnia
  • Rarely psychosis
• Causes of Cushing’s Syndrome can be remembered with the “CAPE” mnemonic: C – Cushing’s disease
• Effects of Cushing’s Syndrome

  • Hypertrophy
  • Type 2 diabetes
  • Dyslipidaemia (raised cholesterol and triglycerides)
  • Osteoporosis
  • Mental health effects: Anxiety, Depression, Insomnia, Rarely psychosis
• Causes of Cushing’s Syndrome

  • Cushing’s disease (a pituitary adenoma releasing excessive ACTH)
  • Adrenal adenoma (an adrenal tumour secreting excess cortisol)
  • Paraneoplastic syndrome
  • Exogenous steroids (patients taking long-term corticosteroids)
• Paraneoplastic Cushing’s syndrome occurs when

  ACTH is released from a tumour somewhere other than the pituitary gland
• Ectopic ACTH


  ACTH from somewhere other than the pituitary gland
• Tumour causing ectopic ACTH

  • Small cell lung cancer
• Ectopic ACTH stimulates excessive cortisol release from

  The adrenal glands
• TOM TIP: 'A high level of ACTH causes skin pigmentation by stimulating melanocytes in the skin to produce melanin, similar to melanocyte-stimulating hormone. This is an important sign of Cushing’s disease and primary adrenal insufficiency. In a patient with Cushing’s syndrome, the pigmentation allows you to determine the cause as excess ACTH, either from Cushing’s disease or ectopic ACTH. This sign is absent in an adrenal adenoma or exogenous steroids.'
• Dexamethasone Suppression Tests


  Used to diagnose Cushing’s syndrome caused by a problem inside the body. No point in using them to diagnose Cushing’s syndrome caused by exogenous steroids. A normal response to dexamethasone is suppressed cortisol due to negative feedback. Dexamethasone causes negative feedback on the hypothalamus, reducing the CRH output. It causes negative feedback on the pituitary, reducing the ACTH output. The lower CRH and ACTH levels result in a low cortisol output by the adrenal glands. A lack of cortisol suppression in response to dexamethasone suggests Cushing’s syndrome.
• Types of dexamethasone suppression test

  • Low-dose overnight test (used as a screening test to exclude Cushing’s syndrome)
  • Low-dose 48-hour test (used in suspected Cushing’s syndrome)
  • High-dose 48-hour test (used to determine the cause in patients with confirmed Cushing’s syndrome)
• Low-dose overnight test


  Dexamethasone (1mg) is given at night (usually 10 or 11 pm), and the cortisol is checked at 9 am the following morning. A normal result is that the cortisol level is suppressed. Failure of the dexamethasone to suppress the morning cortisol could indicate Cushing’s syndrome, and further assessment is required.
• Low-dose 48-hour test


  Dexamethasone (0.5mg) is taken every 6 hours for 8 doses, starting at 9 am on the first day. Cortisol is checked at 9 am on day 1 (before the first dose) and 9 am on day 3 (after the last dose). A normal result is that the cortisol level on day 3 is suppressed. Failure of the dexamethasone to suppress the day 3 cortisol could indicate Cushing’s syndrome, and further assessment is required.
• High-dose 48-hour test


  Carried out the same way as the low-dose test, other than using 2mg per dose (rather than 0.5mg). This higher dose is enough to suppress the cortisol in Cushing’s syndrome caused by a pituitary adenoma
• The high-dose 48-hour test is carried out the same way as the low-dose test, using 2mg per dose instead of 0.5mg
• The higher dose in the high-dose test is enough to suppress the cortisol in Cushing’s syndrome caused by a pituitary adenoma (Cushing’s disease), but not when it is caused by an adrenal adenoma or ectopic ACTH
• Adrenocorticotropic hormone (ACTH)


  Can be measured directly and is suppressed due to negative feedback on the pituitary when excess cortisol comes from an adrenal tumour (or endogenous steroids). It is high when produced by a pituitary tumour or ectopic ACTH (e.g., small cell lung cancer)
• Low Dose Test (Cortisol Result)

  • ACTH: Normal, Cortisol: Low
• High Dose Test (Cortisol Result)

  • ACTH: Low, Cortisol: Normal
• High Dose Test (Cortisol Result)

  • ACTH: Low, Cortisol: High
• High Dose Test (Cortisol Result)

  • ACTH: Not Suppressed, Cortisol: Not Suppressed
• High Dose Test (Cortisol Result)

  • ACTH: Not Suppressed, Cortisol: Low
• A 24-hour urinary free cortisol is an alternative to the dexamethasone suppression test. However, it is cumbersome to carry out and does not indicate the underlying cause
• Other Investigations


  • Full blood count may show a high white blood cell count
  • U&Es may show low potassium if an adrenal adenoma is also secreting aldosterone
  • MRI brain for a pituitary adenoma
  • CT chest for small cell lung cancer
  • CT abdomen for adrenal tumours
• Treatment


  1. The primary treatment is to remove the underlying cause

  2. Trans-sphenoidal (through the nose) removal of pituitary adenoma

  3. Surgical removal of adrenal tumour

  4. Surgical removal of the tumour producing ectopic ACTH (e.g., small cell lung cancer), if possible

  5. If surgical removal of the cause is not possible, another option is to surgically remove both adrenal glands (adrenalectomy) and give the patient life-long steroid replacement therapy
• Nelson’s syndrome involves the development of an ACTH-producing pituitary tumour after the surgical removal of both adrenal glands due to a lack of cortisol and negative feedback. It causes skin pigmentation (high ACTH), bitemporal hemianopia, and a lack of other pituitary hormones
• Metyrapone reduces the production of cortisol in the adrenals and is occasionally used in treating Cushing’s